Thurau SR - Search Results

1

Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide.

Kawano Y, Sasamoto Y, Kotake S, Thurau SR, Wiggert B, Gery I. Kawano Y, et al. Among authors: thurau sr. Curr Eye Res. 1991 Aug;10(8):789-95. doi: 10.3109/02713689109013873. Curr Eye Res. 1991. PMID: 1914511

2

Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals.

Thurau SR, Chan CC, Nussenblatt RB, Caspi RR. Thurau SR, et al. Clin Exp Immunol. 1997 Aug;109(2):370-6. doi: 10.1046/j.1365-2249.1997.4571356.x. Clin Exp Immunol. 1997. PMID: 9276535 Free PMC article.

3

[Immunologic suppression of experimental autoimmune uveitis].

Thurau SR, Caspi RR, Chan CC, Weiner HL, Nussenblatt RB. Thurau SR, et al. Fortschr Ophthalmol. 1991;88(4):404-7. Fortschr Ophthalmol. 1991. PMID: 1838532 German.

4

Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide.

Thurau SR, Chan CC, Suh E, Nussenblatt RB. Thurau SR, et al. J Autoimmun. 1991 Jun;4(3):507-16. doi: 10.1016/0896-8411(91)90162-6. J Autoimmun. 1991. PMID: 1910426

5

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1995 May;25(5):1292-7. doi: 10.1002/eji.1830250524. Eur J Immunol. 1995. PMID: 7774632

6

Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis.

Wildner G, Hünig T, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1996 Sep;26(9):2140-8. doi: 10.1002/eji.1830260927. Eur J Immunol. 1996. PMID: 8814259

7

Endotoxin-induced production of inflammatory mediators by cultured ciliary epithelial cells.

Helbig H, Kittredge KL, Gurley RC, Thurau SR, Palestine AG, Nussenblatt RB. Helbig H, et al. Among authors: thurau sr. Curr Eye Res. 1990 May;9(5):501-5. doi: 10.3109/02713689008999616. Curr Eye Res. 1990. PMID: 2166639

8

Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1994 Nov;24(11):2579-85. doi: 10.1002/eji.1830241103. Eur J Immunol. 1994. PMID: 7957552

9

Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.

Thurau SR, Diedrichs-Möhring M, Fricke H, Arbogast S, Wildner G. Thurau SR, et al. Immunol Lett. 1997 Jun 1;57(1-3):193-201. doi: 10.1016/s0165-2478(97)00058-8. Immunol Lett. 1997. PMID: 9232451 Clinical Trial.

10

Labrafil--a new adjuvant for peptide-specific oral tolerance in rat experimental autoimmune uveitis.

Diedrichs-Möhring M, Thurau SR, Wildner G. Diedrichs-Möhring M, et al. Among authors: thurau sr. Pharmacol Res. 2008 Jan;57(1):26-31. doi: 10.1016/j.phrs.2007.10.008. Epub 2007 Oct 23. Pharmacol Res. 2008. PMID: 18042397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters